These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35213469)

  • 1. Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS Trial.
    Truong TM; Apfelbaum JL; Danahey K; Schierer E; Ludwig J; George D; House L; Karrison T; Shahul S; Anitescu M; Choksi A; Hartman S; Knoebel RW; van Wijk XMR; Yeo KJ; Meltzer DO; Ratain MJ; O'Donnell PH
    Anesth Analg; 2022 Nov; 135(5):929-940. PubMed ID: 35213469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anesthesia providers as stakeholders to adoption of pharmacogenomic information in perioperative care.
    Truong TM; Apfelbaum JL; Schierer E; Danahey K; Borden BA; Karrison T; Shahul S; Anitescu M; Gerlach R; Knoebel RW; Meltzer DO; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2022 Apr; 32(3):79-86. PubMed ID: 34570085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient insights on features of an effective pharmacogenomics patient portal.
    Truong TM; Lipschultz E; Schierer E; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2020 Dec; 30(9):191-200. PubMed ID: 33017129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application.
    Borden BA; Jhun EH; Danahey K; Schierer E; Apfelbaum JL; Anitescu M; Knoebel R; Shahul S; Truong TM; Ratain MJ; O'Donnell PH
    Pharmacogenomics J; 2021 Dec; 21(6):691-711. PubMed ID: 34376788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
    O'Donnell PH; Wadhwa N; Danahey K; Borden BA; Lee SM; Hall JP; Klammer C; Hussain S; Siegler M; Sorrentino MJ; Davis AM; Sacro YA; Nanda R; Polonsky TS; Koyner JL; Burnet DL; Lipstreuer K; Rubin DT; Mulcahy C; Strek ME; Harper W; Cifu AS; Polite B; Patrick-Miller L; Yeo KT; Leung E; Volchenboum SL; Altman RB; Olopade OI; Stadler WM; Meltzer DO; Ratain MJ
    Clin Pharmacol Ther; 2017 Nov; 102(5):859-869. PubMed ID: 28398598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Pharmacogenomics in Opioid Prescribing.
    Wong AK; Somogyi AA; Rubio J; Philip J
    Curr Treat Options Oncol; 2022 Oct; 23(10):1353-1369. PubMed ID: 36001223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients.
    Reizine N; Danahey K; Schierer E; Liu P; Middlestadt M; Ludwig J; Truong TM; van Wijk XMR; Yeo KJ; Malec M; Ratain MJ; O'Donnell PH
    Oncologist; 2021 Nov; 26(11):e2042-e2052. PubMed ID: 34423496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
    Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
    Borden BA; Lee SM; Danahey K; Galecki P; Patrick-Miller L; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Kavitt RT; Meltzer DO; Ratain MJ; O'Donnell PH
    Pharmacogenomics J; 2019 Dec; 19(6):528-537. PubMed ID: 30713337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomic-Based Decision Support to Predict Adherence to Medications.
    Christian C; Borden BA; Danahey K; Yeo KJ; van Wijk XMR; Ratain MJ; O'Donnell PH
    Clin Pharmacol Ther; 2020 Aug; 108(2):368-376. PubMed ID: 32236960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
    Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
    J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing.
    Lee YM; Danahey K; Knoebel RW; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):23-30. PubMed ID: 30531378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Documenting Pharmacogenomic Test Results in Electronic Health Records: Practical Considerations for Primary Care Teams.
    Gammal RS; Berenbrok LA; Empey PE; Massart MB
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
    Ramsey LB; Ong HH; Schildcrout JS; Shi Y; Tang LA; Hicks JK; El Rouby N; Cavallari LH; Tuteja S; Aquilante CL; Beitelshees AL; Lemkin DL; Blake KV; Williams H; Cimino JJ; Davis BH; Limdi NA; Empey PE; Horvat CM; Kao DP; Lipori GP; Rosenman MB; Skaar TC; Teal E; Winterstein AG; Owusu Obeng A; Salyakina D; Gupta A; Gruber J; McCafferty-Fernandez J; Bishop JR; Rivers Z; Benner A; Tamraz B; Long-Boyle J; Peterson JF; Van Driest SL;
    JAMA Netw Open; 2020 Dec; 3(12):e2029411. PubMed ID: 33315113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic considerations for medications in the perioperative setting.
    Jhun EH; Apfelbaum JL; Dickerson DM; Shahul S; Knoebel R; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenomics; 2019 Jul; 20(11):813-827. PubMed ID: 31411557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project".
    O'Donnell PH; Danahey K; Jacobs M; Wadhwa NR; Yuen S; Bush A; Sacro Y; Sorrentino MJ; Siegler M; Harper W; Warrick A; Das S; Saner D; Corless CL; Ratain MJ
    Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):68-75. PubMed ID: 24616296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.
    Lee YM; McKillip RP; Borden BA; Klammer CE; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2017 May; 27(5):179-189. PubMed ID: 28267054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
    Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
    Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients.
    Saulsberry L; Danahey K; Middlestadt M; O'Leary KJ; Nutescu EA; Chen T; Lee JC; Ruhnke GW; George D; House L; van Wijk XMR; Yeo KJ; Choksi A; Hartman SW; Knoebel RW; Friedman PN; Rasmussen LV; Ratain MJ; Perera MA; Meltzer DO; O'Donnell PH
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.